The global Nucleic Acid and Gene Therapies in Neuromuscular Disorders market might, by 2033, amount to US$19.52 billion. This shows an amazing compound annual growth rate (CAGR) of 9.5% from a market valuation of US$7.88 billion in 2023. The increasing prevalence of neuromuscular diseases and the growing need for cutting-edge treatment options are the main factors …
Tag Archives: Gene Therapies in Neuromuscular Disorders Market
Global Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market Set to Flourish, Expected to Reach at a CAGR of 9.5%
The global Nucleic Acid and Gene Therapies in Neuromuscular Disorders market is poised for significant growth, reaching an estimated US$19.52 billion by 2033. This represents a compound annual growth rate (CAGR) of 9.5% from a market size of US$7.88 billion in 2023, according to industry projections. The growth is attributed to the rising prevalence of …